The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InOS Therapies (OSTX) has officially appointed Dr. Robert Langer, the renowned co-founder of Moderna, as a Strategic Advisor to the company. Dr. Langer joins the strategic advisory board to provide expert guidance on the development of the firm's gene-edited cancer immunotherapy pipeline. His primary focus will involve prioritizing oncology assets and selecting optimal candidates for the development of the company's tADC technology. By leveraging Dr. Langer's extensive experience in biotechnology and successful IPOs, OS Therapies aims to accelerate its clinical milestones. This high-profile appointment is expected to significantly bolster investor confidence and provide the micro-cap firm with world-class scientific leadership. The move underscores the company's commitment to advancing its listeria-based immunotherapy platform.